Promising results from ongoing Phase 1/2 clinical trial for X-linked retinitis pigmentosa (XLRP)

October 1, 2019 The Retina Foundation of the Southwest is one of four U.S. centers conducting a Phase 1/2 dose escalation, gene replacement trial for x-linked retinitis pigmentosa (XLRP). On September 26th, the clinical trial sponsor, Applied Genetic Technologies Corporation …

Gene Therapy Trial for Choroideremia

July 23, 2019 In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the efficacy of gene therapy in patients with choroideremia. This late stage trial is based on early Phase …

FFB Pledges $300,000 to Support Dr. Yi-Zhong Wang’s Artificial Intelligence/ Deep Machine Learning Project

July 19, 2019 Yi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge …

What Does “Blindness” Really Mean?

May 20, 2019 Jenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases. By Jenny Schisler There was recently a viral image of …

Phase III Treatment Trial for Stargardt Disease Enrolls First Patient

November 7, 2018 The Retina Foundation of the Southwest was the first site in the world to enroll patients in a new international Phase III Clinical Treatment Trial for Stargardt Disease sponsored by the clinical-stage ophthalmology company Acucela. This study …

Retina Foundation Launches Cutting-Edge Artificial Intelligence Project

September 24, 2018 There is a great need for more information on the progression of vision loss caused by inherited eye diseases and age-related macular degeneration. The Retina Foundation of the Southwest is beginning a new project aimed at developing …

Retina Foundation Participates in International Effort to Treat Stargardt Disease

August 30, 2018 Stargardt disease is the most common form of inherited juvenile macular degeneration. Stargardt disease begins in late childhood and may in some cases lead to legal blindness. It affects approximately ten in 10,000 children and adults. There …

First Patient in Phase 1/2 Clinical Study of Gene Therapy is Treated for X-Linked RP

April 19, 2018 The first human patient has been administered an AAV-based gene therapy treatment for x-linked retinitis pigmentosa (XLRP). This is an exciting clinical milestone for one of the first potential treatments for this disease. The patient is being followed by …

The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease

December 29, 2017 The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust renewed their support for our Texas 1000 Project to identify and genotype 1,000 new patients with retinal degenerative diseases. Since starting this project at the Retina Foundation …

Gene Therapy Trial at the Retina Foundation of the Southwest featured in The Dallas Morning News

October 27, 2017 Mason Two Crow, 22, first came to the Retina Foundation in 2003 with a diagnosis of X-linked retinoschisis, a rare genetic condition affecting the retina. Two years ago he came in for a follow-up appointment where he …

Gene Causing Blindness Found in Texas Hispanic Families

July 18, 2017 The Retina Foundation has been a large part of a genetic study about Retinitis Pigmentosa (RP) with The University of Texas Health Science Center at Houston (UTHealth) School of Public Health. RP is a rare genetic eye …

Silverthorne Lab to Conduct Natural History Study of Usher Syndrome

June 29, 2017 The Rose Silverthorne Retinal Degenerations Laboratory at the Retina Foundation of the Southwest is beginning a natural history trial to study disease progression of Usher Syndrome Type 2a, a recessive genetic condition affecting nearly 25,000 people in …

National Eye Institute Awards $949,804 for a 5-year study of RP

February 21, 2017 Lea Bennett, Ph.D., Postdoctoral Fellow, Rose-Silverthorne Retinal Degenerations Laboratory, studies inherited eye diseases under the direction of Dr. David Birch at the Retina Foundation of the Southwest. Dr. Bennett recently received a five-year grant from the National …

Voelcker Fund Gives $100,000 in Support of Texas 1000 Project

August 2, 2016 The Max and Minnie Tomerlin Voelcker Fund recently gave a $100,000 gift to the Retina Foundation of the Southwest for the Texas 1000 Project, an ambitious project with an overall goal to genotype 1,000 patients with inherited …

Early Detection is Critical for Rare Eye Diseases

July 8, 2016 Achromatopsia is a rare inherited eye disease characterized by decreased vision (20/200), extreme light sensitivity, and the absence of color vision that affects less than 10,000 Americans. There is no current cure for achromatopsia. However, research on …